8-K: ETST Reports Strong Q3, Unveils Governance Overhaul

Earth Science Tech, Inc. announced robust third fiscal quarter 2026 results with significant net income growth and outlined strategic initiatives to enhance corporate governance and achieve $1.4 million in annualized savings.

Summary

• Third fiscal quarter 2026 revenue increased 14.1% year-over-year to $8.4 million.
• Net income surged 341% year-over-year to $910,000 for the quarter.
• Gross profit margin improved to 76.3%, up 71 basis points year-over-year.
• Generated $1.2 million in positive cash from operations fiscal year-to-date.
• Telemedicine platform, Peaks, exceeded $2.0 million in revenue in under a year.
• Reduced outstanding common stock by 3.6% year-over-year through share repurchases, retiring 3,703,296 shares for the nine months ended December 31, 2025.
• Initiated strategic governance enhancements, including rescinding executive employment agreements and reducing board compensation.
• Anticipates $1.4 million in annualized cost savings and projected fiscal 2026 net income growth of over 40%, from $3.3 million to $4.7 million.
• Plans to optimize its portfolio by divesting non-core assets and consolidating operating subsidiaries.
• Will introduce a non-binding say-on-pay advisory vote and an advisory shareholder vote on the retirement of Series B Preferred Stock.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this filing very positively due to strong financial performance, significant net income growth, robust gross margins, and proactive strategic initiatives aimed at enhancing governance and shareholder value, despite a decrease in cash on hand.

Positives

• Revenue increased 14.1% year-over-year to $8.4 million in Q3 2026.
• Net income grew significantly by 341% year-over-year to $910,000 in Q3 2026.
• Gross profit margin improved to 76.3% from 69.2% year-over-year.
• Generated $1.2 million in positive cash from operations fiscal year-to-date.
• Peaks telemedicine platform surpassed $2.0 million in revenue, demonstrating high-margin growth.
• Reduced outstanding common stock by 3.6% year-over-year through share repurchases, indicating capital discipline and shareholder value focus.
• Anticipates $1.4 million in annualized cost savings from strategic initiatives.
• Projects fiscal 2026 net income to grow over 40%, from $3.3 million to $4.7 million.
• No bank debt as of December 31, 2025.
• Working capital improved to $773,000 as of December 31, 2025, from ($36,000) at March 31, 2025.
• Geographic expansion is underway with up to 10 additional state licenses pending.

Negatives

• Cash on hand decreased to $416,000 as of December 31, 2025, from $1.5 million at March 31, 2025, primarily due to investments in inventory and increased operating activity.
• Operating expenses increased to $5.1 million in Q3 2026 from $4.9 million in Q3 2025, driven by advertising/marketing and SG&A, despite a decrease in salaries.
• The company's reported results "do not yet fully capture the operating leverage inherent in the model," suggesting current profitability is not at its full potential.
• The company is still in a "growth and investment cycle," which implies continued capital deployment and potentially lower near-term free cash flow.

Risks

• The markets for the Company's products and services may not perform as expected.
• Costs of goods and services, and other expenses, could fluctuate unfavorably.
• Government regulations could change, impacting operations or profitability.
• Potential for litigations.
• General business conditions could deteriorate.
• Underlying assumptions for forward-looking statements may prove incorrect, causing actual results to differ materially.

Future Outlook

The Company anticipates a clear path to a materially higher earnings baseline through expense rationalization and scale, reinforced by ongoing share repurchases and management's long-term ownership. With calendar 2026 off to a strong start and several geographic and product expansion initiatives underway, the Company believes it is well positioned for accelerating growth in the periods ahead. Management expects approximately $1.4 million in annualized cost savings and projects fiscal 2026 net income to grow over 40%, from $3.3 million to $4.7 million, before considering incremental upside from organic growth.

Management Comments

• "We exited the third fiscal quarter with strong strategic momentum and continued progress across our diversified platform." Giorgio R. Saumat, CEO and Chairman of the Board.
• "Results were largely consistent with the prior quarter and reflected typical seasonality, including holiday timing and temporary macro and supply-related headwinds." Giorgio R. Saumat, CEO and Chairman of the Board.
• "Importantly, multiple operating units are now generating positive cash flow, underscoring the strength and resilience of our portfolio approach." Giorgio R. Saumat, CEO and Chairman of the Board.
• "While our reported results reflect the current stage of our growth and investment cycle, they do not yet fully capture the operating leverage inherent in the model." Giorgio R. Saumat, CEO and Chairman of the Board.
• "Moving ahead, we see a clear and verifiable path to a materially higher earnings baseline through expense rationalization and scale, a view reinforced by our ongoing share repurchases and my long-term ownership position acquired entirely with cash." Giorgio R. Saumat, CEO and Chairman of the Board.
• "With calendar 2026 off to a strong start and several geographic and product expansion initiatives underway, we believe the Company is well positioned for accelerating growth in the periods ahead." Giorgio R. Saumat, CEO and Chairman of the Board.
• "This restructuring represents a significant maturation in Earth Science Techs corporate governance. By voluntarily anchoring executive pay to shareholder approval and reducing near-term fixed costs, management is sending a clear signal that they are stewards of capital first and foremost. The Board fully supports this transition toward a more transparent, performance-driven compensation model." Jeff P. H. Cazeau, Independent Director and Chairman of the Audit Committee.
• "The timing of these transformational actions is supported by improving financial performance and increasing operating leverage across the business. We believe the underlying momentum will become increasingly evident in our financial results over time as these changes take hold and are supported by continued disciplined cost management, accelerating revenue and stronger cash generation." Giorgio R. Saumat, CEO and Chairman of the Board.

Industry Context

StockSavvy.ai notes that Earth Science Tech's focus on telemedicine and compounding pharmacies aligns with broader trends in the healthcare sector towards personalized medicine and digital health solutions. The strategic shift towards enhanced corporate governance and cost rationalization reflects a growing investor demand for transparency and efficiency, particularly among smaller public companies seeking institutional readiness. The divestiture of non-core assets and consolidation of brands are common strategies employed by diversified holding companies to streamline operations and unlock value in competitive markets.

Comparison to Industry Standards

• The 14.1% year-over-year revenue growth is strong, especially for a diversified holding company, and compares favorably to many established healthcare and consumer goods companies that might see single-digit growth.
• The 76.3% gross profit margin is exceptionally high, particularly for a company involved in product sales and healthcare services, suggesting strong pricing power or efficient cost of goods management, potentially outperforming many peers in the pharmaceutical or telemedicine space.
• The 341% net income growth is outstanding and indicates significant operational leverage or successful cost control, far exceeding typical industry growth rates.
• The positive cash from operations and lack of bank debt demonstrate a healthy financial position, which is a strong indicator compared to many growth-focused companies that often rely on debt financing.
• The share repurchase program, reducing outstanding shares by 3.6%, signals a commitment to shareholder returns, a practice often seen in mature, cash-generative companies, which is positive for a company still in a "growth and investment cycle."

Management Changes

Corporate Governance

Legal Proceedings

• No specific legal proceedings were mentioned in the filing, only a general risk of 'litigations' in forward-looking statements.

Related Party Transactions

• No specific related party transactions were disclosed beyond the CEO's long-term ownership position acquired with cash and his voluntary abstention from voting on Series B Preferred Stock retirement.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial results, share repurchases, anticipated cost savings, projected net income growth, and enhanced corporate governance initiatives aimed at increasing transparency and aligning management incentives with shareholder value.
• Executive Officers (CEO, COO): Immediate impact of rescinded employment agreements, waived variable compensation, and at-will employment, but with a stated long-term goal of aligning incentives with shareholder value.
• Directors: Reduced compensation for Board meeting attendance.
• Customers: Potential positive impact from geographic expansion and consolidation of operating subsidiaries under unified brands, which could lead to improved services or product availability.
• Employees: No direct impact mentioned, but portfolio optimization and cost rationalization could imply future operational adjustments.

Next Steps

• Geographic expansion with up to 10 additional state licenses pending.
• Divestiture of non-core assets to optimize capital allocation.
• Consolidation of operating subsidiaries under unified brands.
• Expansion of shareholder engagement.
• Introduction of a non-binding say-on-pay advisory vote at an upcoming shareholder meeting following the filing of the Annual Report on Form 10-K in June 2026.
• Evaluation of measures to rationalize the capital structure.
• Advisory shareholder vote on the retirement of the Series B Preferred Stock.
• Negotiation of new executive and board contracts after the July 2026 annual proxy.

Key Dates

Recommendation

The filing presents exceptionally strong financial results for Q3 2026, including significant revenue growth, a substantial increase in net income, and improved gross margins. The company is generating positive cash from operations and has no bank debt, indicating financial health. Furthermore, the proactive strategic initiatives to enhance corporate governance, reduce costs by $1.4 million annually, and project over 40% net income growth for fiscal 2026 demonstrate a clear commitment to shareholder value and operational efficiency. The share repurchase program further reinforces this positive outlook. These factors collectively suggest a strong positive trajectory for the company, making it an attractive investment.

Keywords

Health and Wellness, Telemedicine, Compounding Pharmacy, Corporate Governance, Share Repurchase, Cost Savings, Net Income Growth, Strategic Initiatives, Holding Company, SEC Filing, ETST